Skip to main content

Table 2 Operating characteristics for the platform design with primary endpoint of disease control rate (DCR)

From: PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer

 

Control Arm

n = 30 for experimental arms

Experiment Arm 1

Experiment Arm 2

Experiment Arm 3

Experiment Arm 4

True DCR

0.70

0.70

0.80

0.90

0.95

Number of patients

42.6

30.0

30.0

30.0

30.0

Start Time (months)

0

0

6

12

18

Probability of claiming success

0.148

0.441

0.833

0.964